AlinaMihaelaAllenMD

PubMed

• Natural history of clinical outcomes and hepatic decompensation in metabolic dysfunction-associated steatotic liver disease.
  Nabil Noureddin, Daniel Q Huang, Ricki Bettencourt, Harris Siddiqi, Abdul M Majzoub, Tarek Nayfeh, Nobuharu Tamaki, Namiki Izumi, Atsushi Nakajima, Ramazan Idilman, Me...> ;Alimentary Pharmacology & Therapeutics. 2024 Apr 3
• Guideline-based management of metabolic dysfunction-associated steatotic liver disease in the primary care setting.
  Alina M Allen, Michael Charlton, Kenneth Cusi, Stephen A Harrison, Kris V Kowdley, Mazen Noureddin, Jay H Shubrook> ;Postgraduate Medicine. 2024 Mar 11
• 10 citations
  Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease.
  Loomba, R., Zobair M Younossi, Saleh A Alqahtani, Khalid Alswat, Yusuf Yilmaz, Caglayan Keklikkiran, Jesús Funuyet-Salas, Manuel Romero-Gómez, Jian-Gao Fan, Ming-Hua Z...> ;Journal of Hepatology. 2024 Mar 1
• Abdominal Body Composition Reference Ranges and Association With Chronic Conditions in an Age- and Sex-Stratified Representative Sample of a Geographically Defined Ame...
  Alexander D Weston, Brandon R Grossardt, Hillary W Garner, Timothy L Kline, Alanna M Chamberlain, Alina M Allen, Bradley J Erickson, Walter A Rocca, Andrew D Rule, Jen...> ;The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences. 2024 Apr 1
• Older Tissue Age Derived From Abdominal Computed Tomography Biomarkers of Muscle, Fat, and Bone Is Associated With Chronic Conditions and Higher Mortality.
  Grossardt, B., Weston, A., Kline, T., Chamberlain, A., Rocca, W., St Sauver, J., Rule, A., Garner, H., Allen, A., Erickson, B.> ;Mayo Clinic Proceedings. 2024 Feb 2
• The future of International Classification of Diseases coding in steatotic liver disease: An expert panel Delphi consensus statement.
  Hagström, H., Adams, L., Allen, A., Byrne, C., Chang, Y., Duseja, A., Grønbæk, H., Ismail, M., Jepsen, P., Kanwal, F., Kramer, J., Loomba, R., Mark, H., Newsome, P., R...> ;Hepatology Communications. 2024 Feb 1
• Introducing W. Ray Kim, MD, our 2024 AASLD president.
  Lim, Y., Kwong, A., Allen, A.> ;Hepatology. 2024 Jan 1
• 3 citations
  Implementation of a liver health check in people with type 2 diabetes.
  Abeysekera, K., Valenti, L., Younossi, Z., Dillon, J., Allen, A., Nourredin, M., Rinella, M., Tacke, F., Francque, S., Ginès, P., Thiele, M., Newsome, P., Guha, I., Es...> ;The Lancet. Gastroenterology & Hepatology. 2024 Jan 1
• Integrating social nutrition principles into the treatment of steatotic liver disease.
  Dana Ivancovsky-Wajcman, Paul N Brennan, Christopher J Kopka, Shira Zelber-Sagi, Zobair M Younossi, Alina M Allen, Karen R Flórez, Jeffrey V Lazarus> ;Communications Medicine. 2023 Nov 10
• Reply: Comparing quantitative MRI technologies in steatotic liver disease.
  Jiahui Li, Alina M Allen, Meng Yin> ;Hepatology. 2024 Apr 1
• Nonalcoholic Fatty Liver Disease Gets Renamed as Metabolic Dysfunction-Associated Steatotic Liver Disease: Progress But With Challenges.
  Alina M Allen, Elisa Pose, K Rajender Reddy, Mark W Russo, Patrick S Kamath> ;Gastroenterology. 2024 Feb 1
• Beyond a liver-gut focus: the evolution of gastroenterology and hepatology in challenging the obesity and steatotic liver disease paradigm.
  Paul N Brennan, Shira Zelber-Sagi, Alina M Allen, John F Dillon, Jeffrey V Lazarus> ;Gut. 2024 Mar 7
• 2 citations
  Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: The Patient and Physician Perspective.
  Wayne Eskridge, Donna R Cryer, Jörn M Schattenberg, Amalia Gastaldelli, Harmeet Malhi, Alina M Allen, Mazen Noureddin, Arun J Sanyal> ;Journal of Clinical Medicine. 2023 Sep 26
• 2 citations
  Uniting to defeat steatotic liver disease: A global mission to promote healthy livers and healthy lives.
  Aleksander Krag, Maria Buti, Jeffrey V Lazarus, Alina M Allen, Jacqueline Bowman, Patrizia Burra, Giacomo Donnini, Ajay Duseja, Manal H El-Sayed, Amalia Gastaldelli, B...> ;Journal of Hepatology. 2023 Nov 1
• 7 citations
  Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study.
  Miquel Serra-Burriel, Adrià Juanola, Feliu Serra-Burriel, Maja Thiele, Isabel Graupera, Elisa Pose, Guillem Pera, Ivica Grgurevic, Llorenç Caballeria, Salvatore Piano,...> ;Lancet. 2023 Sep 16
• 5 citations
  A global action agenda for turning the tide on fatty liver disease.
  Jeffrey V Lazarus, Henry E Mark, Alina M Allen, Juan Pablo Arab, Patrizia Carrieri, Mazen Noureddin, William Alazawi, Naim Alkhouri, Saleh A Alqahtani, Quentin M Anste...> ;Hepatology. 2024 Feb 1
• 16 citations
  A global research priority agenda to advance public health responses to fatty liver disease.
  Jeffrey V Lazarus, Henry E Mark, Alina M Allen, Juan Pablo Arab, Patrizia Carrieri, Mazen Noureddin, William Alazawi, Naim Alkhouri, Saleh A Alqahtani, Marco Arrese, R...> ;Journal of Hepatology. 2023 Sep 1
• 1 citations
  Measuring NAFLD models of care.
  Alina M Allen, Zobair M Younossi, Emmanuel A Tsochatzis, William Alazawi, Shira Zelber-Sagi, Juan Pablo Arab, Kenneth Cusi, Jeffrey V Lazarus> ;Nature Reviews. Gastroenterology & Hepatology. 2023 Oct 1
• 2 citations
  Magnetic resonance elastography-based prediction model for hepatic decompensation in NAFLD: A multicenter cohort study.
  Beom Kyung Kim, Jaclyn Bergstrom, Rohan Loomba, Nobuharu Tamaki, Namiki Izumi, Atsushi Nakajima, Ramazan Idilman, Mesut Gumussoy, Digdem K Oz, Ayse Erden, Emily Truong...> ;Hepatology. 2023 Dec 1
• 3 citations
  Physical Activity and Nonalcoholic Fatty Liver Disease: A Roundtable Statement from the American College of Sports Medicine.
  Jonathan G Stine, Michelle T Long, Kathleen E Corey, Robert E Sallis, Alina M Allen, Matthew J Armstrong, David E Conroy, Daniel J Cuthbertson, Andres Duarte-Rojo, Kat...> ;Medicine and Science in Sports and Exercise. 2023 Sep 1
• 1 citations
  Head-to-head comparison of magnetic resonance elastography-based liver stiffness, fat fraction, and T1 relaxation time in identifying at-risk NASH.
  Jiahui Li, Xin Lu, Zheng Zhu, Kyle J Kalutkiewicz, Taofic Mounajjed, Terry M Therneau, Sudhakar K Venkatesh, Yi Sui, Kevin J Glaser, Safa Hoodeshenas, Armando Manduca,...> ;Hepatology. 2023 Oct 1
• Use of noninvasive scores to predict hepatic steatosis: Flaws and caveats.
  Leon A Adams, Phillip J Schulte, Alina M Allen> ;Hepatology. 2023 Oct 1
• 3 citations
  It is time to expand the fatty liver disease community of practice.
  Jeffrey V Lazarus, Christopher J Kopka, Zobair M Younossi, Alina M Allen> ;Hepatology. 2023 Nov 1
• 7 citations
  American College of Sports Medicine (ACSM) International Multidisciplinary Roundtable report on physical activity and nonalcoholic fatty liver disease.
  Jonathan G Stine, Michelle T Long, Kathleen E Corey, Robert E Sallis, Alina M Allen, Matthew J Armstrong, David E Conroy, Daniel J Cuthbertson, Andres Duarte-Rojo, Kat...> ;Hepatology Communications. 2023 Apr 1
• 42 citations
  Challenges and opportunities in NASH drug development.
  Stephen A Harrison, Alina M Allen, Julie Dubourg, Mazen Noureddin, Naim Alkhouri> ;Nature Medicine. 2023 Mar 1
• Join now to see all

Journal Articles

• Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies.  
  Singh S, Allen AM, Wang Z, Prokop LJ, Murad MH, Loomba R., Clin Gastroenterol Hepatol. 2014 Apr 24
• Survival of recipients of livers from donation after circulatory death who are relisted and undergo retransplant for graft failure.  
  Allen AM, Kim WR, Xiong H, Liu J, Stock PG, Lake JR, Chinnakotla S, Snyder JJ, Israni AK, Kasiske BL., Am J Transplant. 2014 May;14(5):1120-8.